A complex mass is a growth that contains both fluid-filled (cystic) and solid components. Unlike a simple cyst, which is a smooth, fluid-filled sac, a complex mass has features like thick walls, internal dividers called septations, or solid tissue mixed in with the fluid. These mixed characteristics are what make it “complex,” and they’re the reason doctors pay closer attention to these findings than they would to a straightforward cyst.
Complex masses can appear in many parts of the body, including the ovaries, breasts, thyroid, kidneys, and liver. Finding one on an imaging scan doesn’t automatically mean cancer, but it does typically prompt additional testing because the solid components carry a higher risk of being abnormal.
How a Complex Mass Differs From a Simple Cyst
On ultrasound, a simple cyst appears as a dark, round pocket of fluid with thin, smooth walls and nothing inside it. It’s one of the most common and least concerning findings in medical imaging. A complex mass, by contrast, shows a mix of dark (fluid) and bright (solid) areas. The solid portions might appear as thick walls greater than 0.5 mm, thick internal septations, or a distinct solid growth inside the cyst.
There’s also a middle category worth knowing about: a “complicated cyst.” This is a cyst filled with thick or debris-laden fluid that can mimic a solid mass on imaging. It looks different from a complex mass because it lacks a true solid component. The distinction matters because complicated cysts are usually benign, while complex masses with genuine solid tissue require closer evaluation.
Complex Masses in the Breast
A complex cystic and solid breast mass is defined as a cyst with thick walls, thick septations, or a solid component inside it. When more than 50% of the mass is solid, it falls firmly into this category. These masses are classified as BI-RADS category 4, which means they are suspicious enough to warrant a biopsy rather than just monitoring.
The reason for that recommendation is straightforward: complex solid and cystic breast masses carry a malignancy rate between 23% and 31%. That means roughly one in four of these lesions turns out to be cancerous. The typical next step is an ultrasound-guided core needle biopsy targeting the solid portion of the mass. In some cases, surgical excision is recommended instead, particularly when the biopsy results are inconclusive or the mass has other concerning features.
Complex Masses in the Ovaries
Ovarian complex masses are among the most common reasons women undergo further imaging and testing. Radiologists use a scoring system called O-RADS (Ovarian-Adnexal Reporting and Data System) to estimate how likely a mass is to be cancerous, on a scale from 1 to 5.
- O-RADS 2: Includes simple-looking cysts, small endometriomas, and classic dermoid cysts. The malignancy rate in large studies is about 0.5%.
- O-RADS 3: Includes larger smooth cysts (10 cm or more), cysts with slightly irregular walls, or masses with multiple compartments. Malignancy rate is roughly 3.6%.
- O-RADS 4: Includes masses that are multilocular and irregular, or those with a mix of solid and cystic areas. The malignancy rate jumps to about 29.8%.
- O-RADS 5: Includes masses with extensive solid components, irregular solid areas, or signs of spread such as fluid in the abdomen. Malignancy rate is approximately 77.5%.
Several features push an ovarian mass into higher-risk categories. Heavy blood flow through the mass, scored on a color scale of 1 to 4, is one important signal. Rich vascularity (scores of 3 or 4) is characteristic of both advanced primary ovarian tumors and tumors that have spread from other organs. Radiologists also look for a “lead vessel,” a single large blood vessel penetrating from the outer edge into the center of a mass, which is a hallmark of metastatic tumors.
Complex Thyroid Nodules
Thyroid nodules that contain both solid and cystic portions are evaluated using the ACR TI-RADS scoring system. When a thyroid nodule is mixed, only the solid portion gets scored for suspicious features. The cystic part is largely irrelevant to the risk assessment.
The features that raise concern in the solid component include being taller than it is wide on ultrasound, having irregular or spiculated margins, appearing very dark compared to surrounding muscle, and containing tiny bright spots called punctate echogenic foci (which can represent microcalcifications). A taller-than-wide shape is not very sensitive, meaning many cancers won’t have it, but when present it is highly specific for malignancy. Similarly, very low echogenicity (a markedly dark appearance) is a strong indicator of cancer.
Ill-defined margins, on the other hand, are common in benign overgrown thyroid tissue and are not statistically linked to malignancy. This is worth knowing because “ill-defined” on an imaging report can sound alarming but carries a very different meaning from “irregular” or “spiculated.”
What Happens After a Complex Mass Is Found
The first step after discovering a complex mass is usually additional imaging to better characterize it. This might mean a more detailed ultrasound, an MRI, or a CT scan with contrast, depending on where the mass is located. Doctors are looking at the internal architecture of the mass: how much of it is solid, whether blood is flowing through the solid parts, whether the walls and septations are thick or thin, and whether the borders are smooth or irregular.
If imaging alone can’t determine whether the mass is benign, a biopsy is the next step. For most complex masses, this starts with a needle biopsy, either fine-needle aspiration or core needle biopsy. These are minimally invasive, performed with local anesthesia, and typically done on an outpatient basis. The needle is guided by ultrasound or CT imaging to sample the solid component of the mass.
Needle biopsies have limitations, though. In studies of soft tissue masses, fine-needle aspiration correctly identified whether a mass was malignant about 75% of the time, and core biopsy was accurate about 81% of the time. Open surgical biopsy, where a surgeon removes a piece of tissue directly, was accurate 100% of the time and was the only method that reliably determined both the exact type and grade of a tumor. For this reason, when needle biopsy results are inconclusive or when precise diagnosis is critical for planning treatment, an open surgical biopsy or complete removal of the mass may be recommended.
Why “Complex” Does Not Always Mean Cancer
Many complex masses turn out to be benign. Endometriomas (cysts filled with old blood from endometriosis), hemorrhagic cysts (where bleeding has occurred inside a normal cyst), dermoid cysts (which contain a mixture of tissue types including fat and hair), and infected cysts can all appear complex on imaging. Benign fibrous tumors, abscesses, and areas of inflammation can also present as masses with mixed solid and cystic features.
The overall risk of malignancy depends heavily on the organ involved, the specific imaging characteristics, and your age and medical history. A smooth, multilocular ovarian cyst smaller than 10 cm with low blood flow in a premenopausal woman carries very different odds than a large, irregular, highly vascular mass with solid components in a postmenopausal woman. The scoring systems radiologists use, whether BI-RADS for the breast, O-RADS for the ovaries, or TI-RADS for the thyroid, exist precisely to sort these findings into risk categories so that each mass gets the appropriate level of follow-up rather than a one-size-fits-all approach.